Postbiotics Market Report Scope & Overview:

The Postbiotics Market was valued at USD 146.18 Million in 2025 and is expected to reach USD 353.76 Million by 2035, growing at a CAGR of 9.24% from 2026-2035.

The main driver of the Postbiotics Market is the increasing importance that consumers attach to the health of their gut, digestive system, and immune system, along with growing recognition that the use of inactivated microbes can provide scientifically proven effects but with no viability concerns of live probiotics. Postbiotics, according to the definition provided by the International Scientific Association for Probiotics and Prebiotics, are preparations consisting of nonviable microorganisms and their components that provide health benefits and which retain their properties under conditions of heat, oxidation, pressure, and acidity. Therefore, it is possible to include postbiotics into baked products, ready-to-drink products, gummies, powders, and cosmetic products without refrigerated storage. Supplement manufacturers apply clinically tested heat-killed strains and yeast fermentates in order to promote immune function, digestive well-being, stress relief, and sleep, while the feed industry uses postbiotics as an alternative to antibiotics in animal feeding.

In August 2026, Superbrewed Food debuted Thryvia, a postbiotic ingredient built on a Clostridium tyrobutyricum strain and developed in collaboration with German supplier Döhler, reflecting growing investment in next-generation, butyrate-linked postbiotics backed by an expanding body of scientific evidence for gut and metabolic health.

Postbiotics Market Trends

• Rising use of heat-killed probiotic strains in shelf-stable foods, beverages, and gummies.

• Growing adoption of yeast-derived postbiotics in animal feed as antibiotic growth promoter alternatives.

• Expanding clinical research linking postbiotics to immunity, stress, sleep, and metabolic health benefits.

• Increasing integration of postbiotic lysates and ferments in microbiome-friendly skincare formulations.

• Rising number of global distribution partnerships between strain developers and ingredient suppliers.

• Growing interest in postbiotics for infant, elderly, and immunocompromised nutrition where live microbes pose risks.

U.S. Postbiotics Market Outlook

The U.S. Postbiotics Market was valued at USD 47.42 Million in 2025 and is expected to reach USD 110.82 Million by 2035, growing at a CAGR of 8.86% from 2026-2035.

The growth in the U.S. Postbiotics Market remains positively influenced by the presence of an already developed and huge market for dietary supplements, well-informed consumers about the benefits for their gut and immunity, and the availability of postbiotic companies such as Cargill, ADM, and IFF. In particular, Cargill's EpiCor, which is the dried yeast fermentate of Saccharomyces cerevisiae, is present in more finished products than any other postbiotic product. It demonstrates how deeply postbiotics are penetrating into the U.S. supplement supply chain. The growing preference for shelf-stable functional foods, gummies, and beverages makes the postbiotics more preferable than live cultures.

In February 2025, ADM signed an exclusive distribution agreement with Asahi Group Foods for Lactobacillus gasseri CP2305, a postbiotic backed by eight human clinical trials for stress, mood, and sleep support, with global distribution to food manufacturers starting in March 2025.

Postbiotics Market Segment Analysis

• By Source, the Bacteria segment dominated the Postbiotics Market with approximately 61.42% share in 2025, while the Yeast segment is the fastest growing with a CAGR of approximately 10.18%.

• By Application, the Dietary Supplements segment dominated the Postbiotics Market with approximately 41.86% share in 2025, while the Animal Feed segment is the fastest growing with a CAGR of approximately 10.46%.

• By Form, the Dry segment dominated the Postbiotics Market with approximately 67.64% share in 2025, while the Liquid segment is the fastest growing with a CAGR of approximately 10.12%.

• By Function, the Gut Health segment dominated the Postbiotics Market with approximately 28.46% share in 2025, while the Immune Health segment is the fastest growing with a CAGR of approximately 10.34%.

By Source, Bacteria Dominates the Postbiotics Market and Yeast Grows Fastest

Bacteria segment dominated the market in 2025 due to the significant clinical evidence and long commercial history of bacterial postbiotics based on heat-inactivated strains of Lactobacillus and Bifidobacterium bacteria. These bacteria are well-known to manufacturers and regulatory agencies, and their inactivated forms still preserve the biological activities associated with immune system modulation, anti-inflammatory effects and related benefits for digestive health, immune health and skin health. In addition, the standardized bacteria count makes it possible to provide clear dosage claims on capsules, powders and food products fortified with bacterial postbiotics. Continued activity from strain manufacturers in Japan, South Korea, and Europe and the use of heat-treated bacterial ingredients continue to drive their dominance.

Yeast is the fastest-growing segment as more applications of Saccharomyces cerevisiae and Saccharomyces boulardii become popular in human nutrition as well as in animal nutrition. Yeast postbiotics can be produced via fermentation processes which are easy to scale up by using brewing and baking technology. As for animals, yeast cell wall fraction and fermentation metabolites aid in the improvement of gut integrity, nutrient absorption and immune response in case antibiotics are not used as growth promoters anymore. As far as humans are concerned, dried yeast fermentates which have clinical evidence about their ability to help immune and digestive system are used in supplements, beverages and snacks.

By Application, Dietary Supplements Dominates the Postbiotics Market and Animal Feed Grows Fastest

Dietary Supplements held the largest market share in 2025 as capsules, tablets, powders, and gummies continue to be the most efficient way of providing scientifically validated amounts of postbiotics for consumer benefits related to digestion, immunity, stress, and sleep. Postbiotics are stable under heat and storage conditions, eliminating the need for refrigeration and an extra dose for live probiotics. It is also easier for supplement brands to promote the scientific studies conducted on a specific strain. Increased practitioner endorsements, solid sales online, and the growing popularity of combined formula products including prebiotics, probiotics, and postbiotics will drive the market share of Dietary Supplements in North America, Europe, and Asia Pacific.

Animal Feed is the fastest-growing application since feed manufacturers for livestock, poultry, swine, aquaculture, and pet food are using postbiotics to promote digestive health and production by minimizing the use of antibiotics. Regulations in Europe Union, the US, China, and other countries limiting the use of antibiotics in the production process have forced the compound feed manufacturers to opt for safer, stable, and easily stored substitutes. In comparison to live cultures, postbiotics can withstand high temperature during the pelleting process and storage for extended time periods. Growing demand for quality meat, egg, and dairy products in Asia Pacific and Latin America coupled with premiumization in pet food market will continue to make the animal feed the fastest-growing application.

By Form, Dry Dominates the Postbiotics Market and Liquid Grows Fastest

Dry dominated the market in 2025 owing to the stability, shelf-life, and ease of handling and compatibility of powdered and granulated postbiotics that work well with a variety of formats such as capsules, tablets, stick packs, gummies, bakery mixes, infant formula, and feed premixes. Dry postbiotics are resistant to moisture and microbial spoilage, thus easier to store and ship internationally. Postbiotic preparations for commercial use are prepared via heating and inactivation of the product and then spray-dried or freeze-dried, thus creating the dry format naturally. The ability to formulate a variety of products with dry postbiotics in combination with other nutrients, such as vitamins, minerals, and fibers, ensures its leading position.

Liquid is the fastest-growing form as more beverage companies, dairy processors, and personal care firms begin adding postbiotic ferments and filtrates in beverages, fermented dairy products, wellness shots, serums, and toners. The incorporation of liquid postbiotics is easy on the processing lines, where they can be directly added into ready-to-drink formulations without any issues of dispersion. Skin health and skin barrier functions are some of the benefits attributed to liquid postbiotics in skincare applications, thus fueling the increasing demand for postbiotic ingredients from cosmetics manufacturers in Asia Pacific and Europe.

By Function, Gut Health Dominates the Postbiotics Market and Immune Health Grows Fastest

Gut Health dominated the market in 2025 since gut and digestive health are the most evident and best-understood benefits both from consumers and brand perspective while launching postbiotic products. Postbiotics are considered to assist with maintaining the balance of the microbiome, intestinal barrier function, and relief from bloating and irregularity, which is quite similar to messaging from probiotics and prebiotics. Clinical trials on heat-treated strains in cases of irritable bowel syndrome have lent credibility to such statements. Gut health products are often recommended by retailers and healthcare professionals, thus increasing consumer repurchase behavior. Wide range of gut health messaging across all categories ensures the market leadership of this segment.

Immune Health is the fastest-growing function as consumers are becoming more concerned about immune protection all year round and because there is scientific evidence that proves that certain postbiotic strains can contribute to improved immune response and less likelihood of seasonal diseases. Heat-killed Lactococcus lactis strain Plasma and dried yeast fermentates are just some ingredients which have already accumulated a lot of clinical data regarding their effectiveness in immune support. This function has been gaining popularity for its immunity supporting products targeting elderly people, children, and immunocompromised consumers, for whom live bacteria might be contraindicated.

Regional Analysis

North America Postbiotics Market Insights

North America accounted for approximately 38.45% of the global Postbiotics Market in 2025, making it the largest regional market, supported by a mature dietary supplement industry, high consumer awareness of gut and immune health, and the headquarters and R&D operations of leading suppliers such as Cargill, ADM, and IFF. Consumers in the region are early adopters of new biotic ingredients, and supplement brands actively market postbiotics as shelf-stable, science-backed alternatives to live probiotics. Strong e-commerce penetration, practitioner channels, and retail pharmacy networks help new products reach consumers quickly, while pet food and livestock producers continue to adopt postbiotics to reduce antibiotic use.

The United States anchors regional demand, supported by a large base of supplement manufacturers, contract formulators, and functional food brands, along with established pathways that allow many postbiotic ingredients to be marketed under dietary supplement and GRAS frameworks. Domestic clinical research programs and university partnerships continue to build evidence for immune, digestive, and metabolic benefits. Canada contributes steady growth through Health Canada's natural health product framework and ongoing pediatric and gut health research, with Lallemand serving as a key Canadian supplier. Mexico is adding incremental demand through immune and gut health products. These factors are expected to sustain North America's leading position through the forecast period.

Asia Pacific Postbiotics Market Insights

Asia Pacific is the fastest-growing regional market, expanding at a CAGR of approximately 10.86% from 2026 to 2035, driven by rising health awareness, a long tradition of fermented foods, growing disposable incomes, and strong government focus on preventive health and livestock productivity. Japan has decades of experience with heat-killed lactic acid bacteria in foods and beverages, and companies such as Kirin Holdings and Morinaga Milk continue to commercialize clinically studied postbiotic strains for immune and gut health. Rapid growth of functional beverages, supplements, and K-beauty and J-beauty skincare products containing postbiotic ferments is creating broad demand across consumer categories.

Japan anchors regional demand through its mature functional food framework and high consumer familiarity with heat-treated lactic acid bacteria products. China is contributing strong incremental growth as consumers increasingly buy gut and immune health products online and as feed producers adopt postbiotics following the country's ban on antibiotic growth promoters in animal feed. India is expected to record the highest country-level growth, supported by preventive nutrition trends and expanding supplement brands. South Korea continues to lead in postbiotic skincare innovation, while Malaysia and Australia are building research capabilities. These trends are expected to keep Asia Pacific the fastest-growing market through the forecast period.

Europe Postbiotics Market Insights

Europe represents a significant share of the global Postbiotics Market, supported by strong scientific research capabilities, advanced industrial fermentation expertise, and high consumer demand for clean-label gut and immune health products. The region is home to major suppliers such as dsm-firmenich, Kerry Group, Novonesis, BASF, and Phileo by Lesaffre, which continue to expand postbiotic portfolios through acquisitions, partnerships, and launches. Because the European Food Safety Authority has not authorized general probiotic health claims, many brands are turning to postbiotics and strain-specific research to differentiate products. The European Union's ban on antibiotic growth promoters in feed also continues to drive strong postbiotic use in livestock and aquaculture.

Germany anchors regional demand, supported by its robust life sciences infrastructure, large supplement market, and advanced fermentation manufacturing capabilities. France contributes through its long heritage in fermentation and yeast technology, with companies such as Lesaffre and Bioprox Healthcare active in yeast-based postbiotics. The United Kingdom is seeing growing interest in adding postbiotics to mainstream food and beverage products, while Spain has become a production hub following ADM's investment in a Valencia facility that manufactures probiotics and postbiotics on the same site. Italy's startup ecosystem is also focusing on fermentation technologies. These factors are expected to support Europe's steady market expansion through the forecast period.

MEA & Latin America Postbiotics Market Insights

The Middle East & Africa market remains comparatively small but is expanding as rising health awareness, growing supplement consumption, and national wellness and food security strategies increase demand for gut and immune health products. In Saudi Arabia, health and sustainability goals under Vision 2030 are encouraging preventive nutrition and local food processing, while the United Arab Emirates serves as a regional hub for premium supplement and personal care distribution. South Africa is seeing rising interest in gut health and preventive nutrition, along with growing use of feed additives in its poultry industry. Most regional supply is imported from North American, European, and Asian manufacturers, with adoption concentrated in urban retail and pharmacy channels.

Latin America's market is growing as rising consumer awareness of gut health, immunity, and functional nutrition expands demand for postbiotic supplements and fortified foods. Brazil anchors regional demand through its large supplement, dairy, and animal protein industries, where postbiotics are increasingly used in poultry and swine feed to support productivity and reduce antibiotic use. Argentina and Chile are adding demand through fermented dairy and functional beverage categories, while Colombia's growing wellness retail sector supports supplement sales. Multinational suppliers are expanding distribution partnerships across the region to serve both food and feed customers, and continued growth of livestock exports is expected to support steady postbiotic adoption.

Market Dynamics

Growth Drivers: Rising Gut and Immune Health Awareness and Stability Advantages Over Probiotics

Rising gut and immune health awareness represents the primary driver of Postbiotics Market growth, as consumers increasingly connect digestive wellness with immunity, mood, sleep, skin health, and overall well-being. The growing incidence of digestive disorders, including irritable bowel symptoms and gut dysbiosis, along with an aging population and wider interest in preventive healthcare, is encouraging people to adopt daily microbiome-supporting products. Postbiotics also offer a safer option for individuals with weakened gut barriers or compromised immunity, where live microbes may pose risks. Expanding clinical research on specific heat-killed strains, together with rising practitioner attention on the microbiome, continues to build consumer confidence and support repeat purchases.

Stability advantages over probiotics represent a second major growth driver, as postbiotics are made from non-viable cells, cell components, and metabolites that remain effective after exposure to heat, oxygen, acidity, and pressure. This eliminates the refrigeration and overdosing that live cultures often require, lowering logistics and formulation costs for manufacturers. As a result, postbiotics can be added to baked goods, cereals, chocolate, ready-to-drink beverages, gummies, pet treats, and pelleted feed, categories where live probiotics struggle to survive. The ability to guarantee consistent dosing throughout shelf life also supports clearer product claims, which encourages food, supplement, and feed companies to reformulate with postbiotics.

Restraints: Regulatory Uncertainty and Competition from Established Biotics

Regulatory uncertainty represents a meaningful restraint on market growth, as no major authority, including the U.S. FDA, the European Food Safety Authority, or Codex Alimentarius, has yet developed a dedicated framework for postbiotics in foods and dietary supplements. This lack of clear definitions creates ambiguity around ingredient classification, permitted health claims, labeling language, and safety requirements across markets. Companies must often rely on existing pathways such as GRAS notifications, novel food applications, or feed additive registrations, which increases time and cost to market. Limited standardization in how postbiotics are characterized and dosed also makes products harder to compare and slows adoption by cautious manufacturers.

Competition from established biotics represents a further restraint, as probiotics and prebiotics have been on the market much longer, enjoy strong consumer recognition, and benefit from extensive scientific literature and marketing investment. Many consumers still believe live bacteria are essential for gut health and may overlook the benefits of inactivated microbial ingredients. According to Innova Market Insights, only about one-third of consumers globally say they are familiar with postbiotics, pointing to a sizable education gap. High research and production costs, yield optimization challenges, and limited long-term clinical data for some strains further raise commercialization risk, particularly for smaller companies building brands in a crowded gut health category.

Opportunities: Expanding Clinical Research and New Application Areas

Expanding clinical research represents a substantial opportunity, as increasing investment in strain-specific human studies is building evidence for postbiotic benefits in immunity, stress, sleep, metabolic health, skin conditions, and infant nutrition. Clinically documented ingredients help brands support stronger marketing claims and command premium pricing in supplements and functional foods. Partnerships between Japanese and Korean strain developers and global ingredient suppliers are bringing well-studied postbiotics to new regions quickly, while universities and startups explore next-generation strains and specific metabolites such as short-chain fatty acids. Suppliers that pair robust clinical data with scalable manufacturing are well positioned to capture high-value demand in consumer and medical nutrition channels.

New application areas offer a further avenue for expansion, as postbiotics move beyond supplements into cosmetics and personal care, pharmaceuticals, food preservation, sports nutrition, and companion animal health. In skincare, postbiotic lysates and ferments are gaining use for barrier support, soothing sensitive skin, and microbiome-friendly positioning. Pharmaceutical researchers are studying postbiotics for inflammatory skin conditions and gastrointestinal disorders, while food technologists are testing antimicrobial metabolites as natural preservatives. Rising demand for pet supplements and premium pet foods adds another growth channel. Fast-growing consumer markets across Asia Pacific, Latin America, and the Middle East also offer strong long-term opportunities for suppliers expanding their regional presence.

Recent Developments:

• June 2026: Vibrant Nutraceuticals launched Stomach Pro+, a postbiotic digestive health supplement featuring the patented heat-killed LJ88 (Lactobacillus johnsonii #1088) strain to support stomach acid balance and gut microbiome health.

• May 2026: Probi, part of the Symrise Group, launched Rham271h (DSM 6594) at Vitafoods Europe, marking its entry into postbiotic ingredients for functional food, beverage, and dietary supplement applications.

• May 2025: Lallemand entered a global distribution agreement with Kirin Holdings to promote IMMUSE, one of the most clinically documented immune health postbiotics, expanding its reach to consumers worldwide.

• September 2024: Biotenova partnered with Universiti Putra Malaysia to advance research on Lassica K014, a patented Lactobacillus plantarum-derived postbiotic targeting inflammatory skin conditions such as eczema and psoriasis.

• July 2024: Cargill signed an exclusive agreement with Brenntag Specialties Nutrition to distribute its EpiCor postbiotic across the UK, Ireland, France, Germany, the Nordics, and the Baltics.

Postbiotics Market Key Players

• Cargill, Incorporated

• Archer Daniels Midland Company (ADM)

• dsm-firmenich

• Kerry Group plc

• International Flavors & Fragrances Inc. (IFF)

• Novonesis Group

• BASF SE

• Associated British Foods plc

• Lallemand Inc.

• Phileo by Lesaffre

• MCLS Europe B.V.

• Kirin Holdings Company, Limited

• Morinaga Milk Industry Co., Ltd.

• CJ CheilJedang Corp.

• Sami-Sabinsa Group

• Probi AB

• Biotenova Sdn. Bhd.

• Bioprox Healthcare

• SILAB

• Stratum Nutrition

Postbiotics Market Report Scope: